(Q36799838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Autocrine VEGF loops, signaling pathways, and acute leukemia regulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ana Paula Elias

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sérgio Dias

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Rita Fragoso

1

1 reference

16 August 2017

Ana Paula Elias

2

1 reference

16 August 2017

Sérgio Dias

3

1 reference

16 August 2017

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

481-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

Vascular endothelial growth factor is a secreted angiogenic mitogen

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Angiogenesis in acute and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

VEGF and myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

The HIF family member EPAS1/HIF-2α is required for normal hematopoiesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

The evolution of thalidomide and its IMiD derivatives as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Efficacy and safety of thalidomide in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601064720

10.1080/10428190601064720

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454587%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference